Cereno Scientific AB logo

CRNO TO1 B - Cereno Scientific AB News Story

SEK0.405 -0.0  -4.7%

Last Trade - 01/03/21

Sector
Healthcare
Size
Micro Cap
Market Cap £6.43m
Enterprise Value £5.80m
Revenue £n/a
Position in Universe 1685th / 1874

BRIEF-Cereno Scientific Receives Patent Approval In US For Use Of Drug Candidate CS1

Thu 13th September, 2018 9:15am
Sept 13 (Reuters) - Cereno Scientific AB  CRNOSb.TE :
    * CERENO SCIENTIFIC RECEIVES PATENT APPROVAL IN US FOR USE
OF DRUG
CANDIDATE CS1
    * POSSIBILITY OF A PATENT EXTENSION OF AN ADDITIONAL FIVE
YEARS
MAXIMUM
    * US PATENT WILL BE VALID THROUGH 2035

Source text for Eikon:  ID:nWkr7Fx8nP 
Further company coverage:  CRNOSb.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.